GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inhalation Sciences Sweden AB (XSAT:ISAB) » Definitions » Total Equity

Inhalation Sciences Sweden AB (XSAT:ISAB) Total Equity : kr7.81 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Inhalation Sciences Sweden AB Total Equity?

Inhalation Sciences Sweden AB's total equity for the quarter that ended in Dec. 2024 was kr7.81 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Inhalation Sciences Sweden AB Total Equity Historical Data

The historical data trend for Inhalation Sciences Sweden AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhalation Sciences Sweden AB Total Equity Chart

Inhalation Sciences Sweden AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.48 19.68 7.55 12.95 7.81

Inhalation Sciences Sweden AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.95 12.16 11.24 10.22 7.81

Inhalation Sciences Sweden AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Inhalation Sciences Sweden AB's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=10.529-2.722
=7.81

Inhalation Sciences Sweden AB's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=10.529-2.722
=7.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inhalation Sciences Sweden AB Total Equity Related Terms

Thank you for viewing the detailed overview of Inhalation Sciences Sweden AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Inhalation Sciences Sweden AB Business Description

Traded in Other Exchanges
N/A
Address
Halsovagen 7, Huddinge, SWE, 141 57
Inhalation Sciences Sweden AB develops and commercializes patented lab instrument for inhalation research. Its products include PreciseInhale an advanced laboratory system used to measure inhaled particles and their effect on lungs, and LaminarPace tool for drying small amounts of the drug substance.

Inhalation Sciences Sweden AB Headlines

No Headlines